title: [Side effect and supportive care to combination of gemcitabine and cisplatin chemotherapy for the advanced urothelial cancer].
authors.forename: Yoichiro
authors.initials: Y
authors.lastname: Kato
authors.forename: Junya
authors.initials: J
authors.lastname: Sato
authors.forename: Renpei
authors.initials: R
authors.lastname: Kato
authors.forename: Ryo
authors.initials: R
authors.lastname: Takata
authors.forename: Wataru
authors.initials: W
authors.lastname: Obara
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002945:Cisplatin / Q000009:adverse effects; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D014571:Urologic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D000093542:Gemcitabine
chemical_list: D000970:Antineoplastic Agents; D003841:Deoxycytidine; D002945:Cisplatin; D000093542:Gemcitabine